DETALUS ADVISORS, LLC – AbbVie Inc. Transaction History
DETALUS ADVISORS, LLC portfolio value:
$498,000
portfolio value
DETALUS ADVISORS, LLC quarter portfolio value change:
-12.37%
quarter
AbbVie Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.62% | -100 shares | -86K | $134.21 | 3.71K |
| Q2 2022 | share | 0.00% | 0 shares | -34K | $153.16 | 3.81K | |
| Q1 2022 | share | Decrease | -38.62% | -2.4K shares | -223K | $162.11 | 3.81K |
| Q4 2021 | share | Decrease | -1.43% | -90 shares | 161K | $135.93 | 6.21K |
| Q3 2021 | share | Increase | +5.88% | 350 shares | 9K | $106.6 | 6.30K |
| Q2 2021 | share | Increase | 0.00% | 5.95K shares | 671K | $110.09 | 5.95K |
| Q3 2020 | share | Decrease | -100.00% | -2.47K shares | -243K | $82.47 | 0 |
| Q2 2020 | share | Increase | 0.00% | 2.47K shares | 243K | $91.35 | 2.47K |
| Q1 2020 | share | Decrease | -100.00% | -2.42K shares | -215K | $69.88 | 0 |
| Q4 2019 | share | Increase | 0.00% | 2.42K shares | 215K | $80.14 | 2.42K |